Global Ultrasound Devices Market: By technology, Display Type, Portability, Application, End Users, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025-2033

The ultrasound devices market is currently experiencing a transformative phase characterized by steady growth and technological innovation. Valued at approximately US$ 9.35 billion in 2024, the market is projected to expand significantly, reaching an estimated US$ 14.18 billion by 2033. This growth reflects a compound annual growth rate (CAGR) of 4.74% over the forecast period from 2025 to 2033, highlighting the increasing demand for ultrasound technology across various healthcare sectors.

Several key trends are driving this evolution within the ultrasound devices market. One of the most impactful developments is the integration of artificial intelligence (AI) into ultrasound systems. AI enhances image analysis, automates measurements, and assists clinicians in making faster and more accurate diagnoses, thereby improving patient outcomes and workflow efficiency. Alongside AI, there is a notable surge in the adoption of portable point-of-care ultrasound (POCUS) devices.

Noteworthy Market Developments

The ultrasound devices market is currently undergoing significant strategic realignments, driven by new partnerships with major technology companies and increasing vertical integration among key players. These shifts are transforming the competitive landscape, as companies seek to leverage advanced technologies and streamline their operations to gain an edge. A notable example occurred in October 2025 when Sonomind secured a substantial investment of €3 million (approximately $3.53 million) aimed at advancing its Neuromodulation Ultrasound Device. This funding included €2 million ($2.35 million) in seed capital from Critical Path Ventures alongside an additional €1 million provided through the French government's France 2030 initiative.

In response to these evolving market dynamics, smaller players in the ultrasound device industry are adopting API-first strategies to remain competitive and relevant. By focusing on developing application programming interfaces (APIs) that facilitate seamless integration with other healthcare technologies, these companies aim to provide more flexible, interoperable solutions that fit smoothly into existing clinical workflows. For instance, in August 2025, Sonio introduced a new suite of ultrasound offerings specifically designed for maternal care in the United States. These products emphasize ease of integration with current technology stacks used by healthcare providers, aiming to enhance both diagnostic accuracy and operational efficiency.

Core Growth Drivers

The global rise in chronic diseases, especially cardiovascular disorders, cancers, and liver conditions, is fueling an increasing demand for accurate and real-time diagnostic tools such as ultrasound. These chronic illnesses represent a significant and growing health burden worldwide, necessitating early and precise detection methods to improve patient outcomes. The World Health Organization's 2024 Global Burden of Disease Report highlights that cardiovascular diseases (CVDs) alone are responsible for approximately 20.5 million deaths annually, underscoring the urgent need for effective diagnostic strategies. Early diagnosis of such conditions is critical, as timely intervention can substantially reduce mortality rates and improve quality of life for millions of patients globally.

Emerging Opportunity Trends

The post-pandemic era has firmly established telemedicine as a fundamental component of healthcare delivery, with the wireless ultrasound devices market playing a crucial role in addressing geographic and specialist shortages. Tele-ultrasound technology has emerged as a transformative solution, enabling healthcare providers to extend diagnostic imaging services to remote and underserved areas where access to specialists is limited. According to a 2024 study published in JAMA, approximately 68% of rural clinics in the United States have incorporated tele-ultrasound into prenatal care programs. The availability of FDA-approved wireless ultrasound devices largely drives this widespread adoption.

Barriers to Optimization

A persistent skills gap poses a significant threat to the effective utilization of ultrasound devices in the market, undermining their potential benefits in clinical practice. According to a 2024 survey conducted by the American Society of Echocardiography, nearly 43% of primary care providers reported lacking confidence in operating advanced ultrasound systems, even after completing basic training. This lack of confidence reflects broader challenges in mastering increasingly sophisticated ultrasound technologies, which require more than rudimentary knowledge for optimal use. As ultrasound devices become more complex and feature-rich, the gap between available technology and user proficiency widens, potentially limiting the accuracy and clinical value of ultrasound imaging.

Detailed Market Segmentation

By Technology, diagnostic ultrasound technology holds a commanding dominance in the ultrasound devices market, capturing an impressive 92.4% share. This overwhelming preference is largely due to its non-invasive nature, which ensures patient safety while delivering high-quality imaging. Unlike other diagnostic methods that may involve radiation or invasive procedures, ultrasound uses sound waves to visualize internal structures, making it an ideal choice for repeated use and monitoring without risk. This safety profile has made diagnostic ultrasound a cornerstone in medical imaging, widely trusted across various healthcare specialties.

By Display Type, color ultrasound devices dominate the ultrasound devices market, commanding an impressive 90.9% share, largely because of their superior diagnostic accuracy compared to traditional grayscale systems. The ability to visualize blood flow, tissue vascularity, and movement in real-time with vibrant color imaging provides clinicians with critical information that enhances diagnostic confidence and precision. This advanced visualization capability is particularly valuable in complex cases where subtle differences in tissue characteristics or blood flow patterns can influence clinical decisions and patient outcomes.

By Portability, cart-based ultrasound systems continue to dominate the market with a substantial 57.31% share, maintaining their status as essential equipment in emergency rooms (ER) and intensive care units (ICU). Their robust performance, large display screens, and advanced imaging capabilities make them the preferred choice for critical care environments where quick and accurate diagnostics are paramount. A notable example of innovation within this category is Philips' Lumify system integrated with Reacts(R) tele-guidance technology.

By Application, radiology holds a commanding 29.6% share of the ultrasound devices market, largely propelled by the growing adoption of elastography technology. Elastography, a non-invasive imaging technique that measures tissue stiffness, has revolutionized diagnostic capabilities within radiology by providing more precise assessments of various conditions. This advancement has contributed significantly to radiology's leadership position in the ultrasound market, offering clinicians enhanced tools to improve patient outcomes while reducing the need for invasive procedures.

Segment Breakdown

By Technology

• Diagnostic Ultrasound
• Therapeutic Ultrasound

By Display Type

• Color Ultrasound Devices
• Black and White (B/W) Ultrasound Devices

By Portability

• Trolley/Cart-based Ultrasound Devices
• Compact/Handheld Ultrasound Devices
• Point-of-care Ultrasound Devices

By Application

• Radiology/General Imaging
• Cardiology
• Gynecology
• Vascular
• Urology
• Others

By End User

• Hospitals
• Surgical Centers
• Diagnostic Centers
• Ambulatory Surgical Centers
• Maternity Centers
• Others

By Region

• North America
• The U.S.
• Canada
• Mexico
• Europe
• Western Europe
• The UK
• Germany
• France
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Poland
• Russia
• Rest of Eastern Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East & Africa (MEA)
• Saudi Arabia
• South Africa
• UAE
• Rest of MEA
• South America
• Argentina
• Brazil
• Rest of South America

Geography Breakdown

• The Asia Pacific region commands a significant 29.65% share of the global ultrasound devices market revenue, driven by several converging factors, such as rapidly aging populations, government-led initiatives to digitize healthcare, and a growing preference for portable ultrasound devices. These trends are reshaping the healthcare landscape across the region, increasing demand for advanced diagnostic tools that can provide efficient, accurate imaging in both urban and rural settings.
• Within the Asia Pacific, China and India are the primary contributors to this growth. China alone accounts for approximately 40% of the region's expansion, propelled by ambitious government programs like the "Healthy China 2030" initiative. This comprehensive strategy aims to modernize healthcare infrastructure nationwide, with one of its key mandates requiring that 90% of primary care centers be equipped with ultrasound machines by 2025.

Leading Market Participants

• Canon Medical Systems Corporation
• FUJIFILM OneSite, Inc.
• GE Healthcare
• B. Braun
• Hologic Inc.
• Konica Minolta Inc.
• Koninklijke Philips N.V.
• Mindray Medical International Limited
• Samsung Medison Co., Ltd.
• Siemens Healthier AG
• Analogic Corporation
• Neusoft Corporation
• Trivitron Healthcare
• CHISON Medical Technologies Co., Ltd.
• Terason
• Esaote SpA
• Other Prominent Players